Esophageal And Gastric Cancer

More documents

Recommendations

Info

Gastric Cancer • Epidemiology: M:F = 2.3:1, median age 70 • 40% of cases are in China • Blood Group A – higher incidence • Signs and Symptoms: advanced presentation: pain, weight loss, vomiting, early satiety • Dx: Endoscopy, CT, EUS, PET • Pathology: adenoca – 95%
Gastric Cancer: Worldwide incidence 798,000 New Cases in 1990 Western Europe Eastern Europe Japan Australia/ New Zealand China Northern Africa Southern Africa Central America North America Male 16.4 Female 8.2 Male 36.3 Female 16.9 Male 77.9 Female 33.3 Male 10.8 Female 4.9 Male 43.6 Female 19.0 Male 5.9 Female 2.6 Male 11.5 Female 4.3 Male 18.6 Female 13.3 Male 8.4 Female 4.0
Page 1: Esophageal and Gastric Cancer: Upda
Page 4 and 5: Esophageal Cancer • Epidemiology:
Page 6 and 7: Timing of Oncology Treatment Neoadj
Page 8 and 9: Neoadjuvant Therapy for Esophageal
Page 10 and 11: Preoperative Chemoradiation of Esop
Page 12 and 13: Trimodality Trial (CALGB 9781) •
Page 14 and 15: Trimodality Trial • Conclusion: l
Page 16 and 17: Localized Esophageal Cancer: • RT
Page 18 and 19: New Agents For Combined Modality Tr
Page 20 and 21: Treatment: Metastatic Disease •Pr
Page 22 and 23: Chemotherapy for Advanced Esophagea
Page 26 and 27: Gastric Cancer 1930-1997 Age-adjust
Page 28 and 29: Neoadjuvant Question in Gastric Can
Page 30 and 31: Feb 20, 2009 - chemotherapy alone v
Page 32 and 33: Treatment of Localized Disease •
Page 34 and 35: Unresectable Gastric Cancer • Sur
Page 36 and 37: New Drugs in the Treatment of Advan
Page 38 and 39: Taxotere in Advanced Gastric Cancer
Page 40 and 41: Phase III Study Comparing Capecitab
Page 42 and 43: OXALIPLATIN • Less anemia • Les
Page 44 and 45: S1: Promising Drug under Investigat
Page 46 and 47: ECOG/CALGB 80403
Page 48 and 49: ASCO GI: Advanced Esophageal Cancer
Page 50: ASCO GI: Nutritional Support May Im

Esophageal And Gastric Cancer

Create successful ePaper yourself

Delete template?

Save as template?